Մալթա - անգլերեն - Medicines Authority

fresenius kabi italia s.r.l via camagre 41, 37063 isola della scala (vr) , italy - etoposide - concentrate for solution for infusion - etoposide 20 mg/ml - antineoplastic agents

Բելգիա - անգլերեն - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi sa-nv - zinc sulfate heptahydrate - eq. zinc sulfate 0,004 mg/ml; sodium acetate trihydrate - eq. sodium acetate 1,1 mg/ml; sodium glycerophosphate hydrate - eq. sodium glycerophosphate 1,4 mg/ml; magnesium sulfate heptahydrate - eq. magnesium sulfate 0,41 mg/ml; glycine 3,7 mg/ml; valine 2,1 mg/ml; arginine 4,1 mg/ml; leucine 2,5 mg/ml; potassium chloride 1,5 mg/ml; serine 2,2 mg/ml; proline 3,8 mg/ml; alanine 4,7 mg/ml; lysine acetate - eq. lysine 2,2 mg/ml; histidine 1 mg/ml; threonine 1,5 mg/ml; tryptophan 0,68 mg/ml; soya oil 12 mg/ml; triglycerides medium chain 12 mg/ml; taurine 0,34 mg/ml; olive oil 9,8 mg/ml; fish oil rich in omega-3-acids 5,9 mg/ml; glucose monohydrate - eq. glucose 89 mg/ml; calcium chloride dihydrate - eq. calcium chloride 0,19 mg/ml; tyrosine 0,14 mg/ml; isoleucine 1,7 mg/ml; methionine 1,5 mg/ml; phenylalanine 1,7 mg/ml - emulsion for infusion - alanine 4.7 mg/ml; arginine 4.1 mg/ml; glycine 3.7 mg/ml; histidine 1 mg/ml; isoleucine 1.7 mg/ml; leucine 2.5 mg/ml; lysine acetate; methionine 1.5 mg/ml; phenylalanine 1.7 mg/ml; proline 3.8 mg/ml; serine 2.2 mg/ml; taurine 0.34 mg/ml; threonine 1.5 mg/ml; tryptophan 0.68 mg/ml; tyrosine 0.14 mg/ml; valine 2.1 mg/ml; calcium chloride dihydrate; sodium glycerophosphate hydrate; magnesium sulfate heptahydrate; potassium chloride 1.5 mg/ml; sodium acetate trihydrate; zinc sulfate heptahydrate; glucose monohydrate; soya oil 12 mg/ml; triglycerides medium chain 12 mg/ml; olive oil 9.8 mg/ml; fish oil, rich in omega-3 acids 5.9 mg/ml - combinations

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

chiesi australia pty ltd - cannabidiol, quantity: 100 mg/ml - oral liquid, solution - excipient ingredients: sesame oil; sucralose; ethanol absolute; flavour - epidyolex is indicated for use as adjunctive therapy of seizures associated with lennox-gastaut syndrome (lgs) or dravet syndrome (ds) for patients 2 years of age and older.

Մալթա - անգլերեն - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - concentrate for solution for infusion - pemetrexed 25 mg/ml - antineoplastic agents

Մալթա - անգլերեն - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - concentrate for solution for infusion - pemetrexed 25 mg/ml - antineoplastic agents

Մալթա - անգլերեն - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - concentrate for solution for infusion - pemetrexed 25 mg/ml - antineoplastic agents

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

nestle australia ltd - phenylalanine -

Ավստրալիա - անգլերեն - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ceva animal health pty ltd - phenylalanine-d; isoleucine - l; carnitine - l - parenteral liquid/solution/suspension - phenylalanine-d amino acid-phenylalanine-d active 4.0 mg/ml; isoleucine - l amino acid-isoleucine-l active 5.33 mg/ml; carnitine - l vitamin-bt active 200.0 mg/ml - nutrition & metabolism - dog | horse | bitch | castrate | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at - mineral and nutritional additive | acetonaemia | actinobacillosis | amino acid supplement | amino acids | bone fragility | bone growth | calcium supplement | cartilage strength | copper deficiency | egg shell | fatty acid deficiency | fatty liver | glucose | grass tetany | hepatotoxic drugs | hypocalcaemia | hypomagnesaemia | ileitis | iodine deficiencies | lactating | laxative | l-carnitine supplement | liver abscess | liver damage | lysine deficiencies | milk fever | mineral additive | myopathies | myositis syndrome | pangamic acid | phosphorous supplement | rickets | selenium deficiency | shell strength | soft bone disease | vitamin b12 | vitamin d supplement | vitamin e deficiencies | zinc deficiencies

Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - alanine 16 g/l;  ;  ;  ; arginine 11.3 g/l;  ;  ; aspartic acid 3.4 g/l;  ;  ; glutamic acid 5.6 g/l;  ;  ; glycyl-l-glutamine 30.27 g/l;  ; glycyl-l-tyrosine 3.45 g/l; histidine 6.8 g/l;  ;  ; isoleucine 5.6 g/l;  ;  ;  ; leucine 7.9 g/l;  ;  ;  ; lysine acetate 12.7 g/l;  ;  ;  ; methionine 5.6 g/l;  ; phenylalanine 5.85 g/l;  ;  ;  ;  ; proline 6.8 g/l;  ; serine 4.5 g/l;  ;  ;  ; threonine 5.6 g/l;  ;  ;  ; tryptophan 1.9 g/l;  ;  ; valine 7.3 g/l;  ;   - solution for infusion - 134 g/l - active: alanine 16 g/l       arginine 11.3 g/l     aspartic acid 3.4 g/l     glutamic acid 5.6 g/l     glycyl-l-glutamine 30.27 g/l   glycyl-l-tyrosine 3.45 g/l histidine 6.8 g/l     isoleucine 5.6 g/l       leucine 7.9 g/l       lysine acetate 12.7 g/l       methionine 5.6 g/l   phenylalanine 5.85 g/l         proline 6.8 g/l   serine 4.5 g/l       threonine 5.6 g/l       tryptophan 1.9 g/l     valine 7.3 g/l     excipient: citric acid monohydrate water for injection - glamin provides amino acids as part of parenteral nutrition therapy, when oral or enteral nutrition is impossible, insufficient or contraindicated especially in patients with a moderate to severe catabolic status.

Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - alanine 14 g/l;  ;  ; arginine 12 g/l;  ;  ; calcium chloride dihydrate 0.56 g/l (as dihydrate. equivalent to 0.74 g/l calcium chloride dihydrate);  ; glycine 11 g/l;  ;  ;  ; histidine 3 g/l;  ;  ;  ; isoleucine 5 g/l;  ;  ;  ; leucine 7.4 g/l;  ;  ;  ;  ; lysine acetate 9.3 g/l equivalent to l-lysine 6.6 g/l;  ;  ; magnesium sulfate 1.2 g/l (as heptahydrate. equivalent to 2.47 g/l magnesium sulphate heptahydrate);  ;  ; methionine 4.3 g/l;  ;  ; phenylalanine 5.1 g/l;  ;  ; potassium chloride 4.48 g/l;  ; proline 11.2 g/l;  ; serine 6.5 g/l;  ;  ;  ; sodium acetate trihydrate 3.4 g/l (as trihydrate. equivalent to sodium acetate trihydrate 5.62 g/l);  ;  ;  ; sodium glycerophosphate 4.18 g/l (as hydrate. amount added corrected for actual water content of substance);  ; taurine 1 g/l;  ; threonine 4.4 g/l;  ;  ;  ; tryptophan 2 g/l;  ;  ;  ; tyrosine 0.4 g/l;  ; valine 6.2 g/l;  ;  ;  ;  ; zinc sulfate 0.023 g/l (as heptahydrate. equivalent to zinc sulphate 0.0129 g);  ; glucose monohydrate 462 g/l equivalent to glucose (anhydrous) 420 g/l;  ;  ; fish oil 30 g/l; medium-chain triglycerides 60 g/l;  ; olive oil 50 g/l;  ; soya oil 60 g/l;   - emulsion for infusion - active: alanine 14 g/l     arginine 12 g/l     calcium chloride dihydrate 0.56 g/l (as dihydrate. equivalent to 0.74 g/l calcium chloride dihydrate)   glycine 11 g/l       histidine 3 g/l       isoleucine 5 g/l       leucine 7.4 g/l         lysine acetate 9.3 g/l equivalent to l-lysine 6.6 g/l     magnesium sulfate 1.2 g/l (as heptahydrate. equivalent to 2.47 g/l magnesium sulphate heptahydrate)     methionine 4.3 g/l     phenylalanine 5.1 g/l     potassium chloride 4.48 g/l   proline 11.2 g/l   serine 6.5 g/l       sodium acetate trihydrate 3.4 g/l (as trihydrate. equivalent to sodium acetate trihydrate 5.62 g/l)       sodium glycerophosphate 4.18 g/l (as hydrate. amount added corrected for actual water content of substance)   taurine 1 g/l   threonine 4.4 g/l       tryptophan 2 g/l       tyrosine 0.4 g/l   valine 6.2 g/l         zinc sulfate 0.023 g/l (as heptahydrate. equivalent to zinc sulphate 0.0129 g)   excipient: glacial acetic acid nitrogen water for injection active: glucose monohydrate 462 g/l equivalent to glucose (anhydrous) 420 g/l     excipient: hydrochloric acid nitrogen water for injection active: fish oil 30 g/l medium-chain triglycerides 60 g/l   olive oil 50 g/l   soya oil 60 g/l   excipient: dl-alpha tocopherol egg lecithin glycerol nitrogen sodium hydroxide sodium oleate water for injection - parenteral nutrition for adults and children aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated